Chronic sensory or sensorimotor polyneuropathy is a common clinical problem
referred to neurologists. Even with modern diagnostic approaches, up to on
e-third of them will remain unclassified. Recent studies have provided insi
ght into their clinical spectrum and course. The age of onset tends to be i
n the sixth to seventh decade of life. Symptoms progress slowly, and most p
atients present with paresthesias or pain. Cryptogenic polyneuropathies are
almost exclusively axonal on clinical, electrophysiologic, and histologic
grounds. Overall, the prognosis is favorable, and only a small minority of
patients develop significant motor disability or physical incapacitation. P
rogression to a nonambulatory state essentially never occurs. Successful ma
nagement should focus on rational pharmacotherapy for painful paresthesias
combined with patient education and reassurance.